(19)

(11)

EP 4 770 643 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24772861.1 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  A61K 31/437(2006.01) A61P 35/00(2006.01) A61K 45/06(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/437; A61P 35/00; A61K 45/06   C-Sets: A61K 31/437, A61K 2300/00; (86) International application number: PCT/US2024/044669 (87) International publication number: WO 2025/049904 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 31.08.2023 US 202363535905 P (71) Applicant: Antares Therapeutics, Inc. Boston, Massachusetts 02110 (US)	(72) Inventors: MILGRAM, Benjamin C. Weston, Massachusetts 02493 (US) WHITE, Ryan D. Somerville, Massachusetts 02144 (US) ST. JEAN, JR., David Boston, Massachusetts 02110 (US) GUZMAN-PEREZ, Angel Belmont, Massachusetts 02478 (US) (74) Representative: Lavoix  2, place d'Estienne d'Orves 75441 Paris Cedex 09 75441 Paris Cedex 09 (FR)